A simple procedure for rapid identification of Clostridium botulinum type A and B colonies from cultures and stool samples from infants with botulism was devised. The stool samples were directly streaked on C. botulinum isolation medium containing selective inhibitory agents. Typical lipase-positive colonies that appeared within 24 to 48 h were examined for the presence of botulinal toxin by the enzyme-linked immunosorbent assay and conventional mouse toxicity test. The amount of toxin associated with 48-h colonies of stock strains was comparable to that of 96-h broth culture. The quantity of toxin present in a single colony or combination of two was shown to be sufficient for toxin detection by the enzyme-linked immunosorbent assay. Of 42 additional stock strains tested in this manner, 41 (97.5%) were identified as toxigenic C. botulinum type A or B. The remaining one strain also proved to be toxigenic when it was tested as a concentrated cell suspension. This procedure should prove useful for large-scale serological screening of food and clinical specimens.
Clostridium botulinum types A and B are phenotypically indistinguishable from C. sporogenes, except for toxin production. Therefore, identification of suspected isolates from food or clinical specimens requires the demonstration of toxigenic potential. The current procedure for isolation and identification of C. botulinum involves a spore selection technique with heat or ethanol treatment in combination with nonselective enrichment culture and agar plating methods (6, 7) . The botulinum toxin elaborated by the isolates in the enrichment or 4-day-old broth culture is then demonstrated by mouse bioassay. The entire process of isolation and identification of the organism as C. botulinum may require 7 to 14 days. The isolation of suspected colonies on nonselective medium is often complicated by the growth of a wide variety of fecal organisms. Spore selection by heat or ethanol treatment, on the other hand, may lead to the elimination of low-sporulating strains of C. botulinum with false-negative results (4) .
A recently formulated C. botulinum isolation (CBI) medium (4) allows selective recovery of type A, B, and F organisms associated with infant botulism by direct streaking of the test specimens, obviating the need for enrichment culturing or treatment with heat or ethanol. Our newly developed enzyme-linked immunosorbent assay (ELISA) for type A (1) and B (M. Dezfulian and J. G. Bartlett, Diagn. Microbiol. Infect. Dis., in press) botulinum toxins provides a useful alternative to the mouse bioassay for demonstration of the botulinum toxins in culture (1; Dezfulian and Bartlett, in press) and fecal specimens (3) .
The present communication deals with selective isolation and direct demonstration of toxigenicity of C. botulinum type A and B colonies by the ELISA.
MATERIALS AND METHODS
Organisms. The organisms included 50 strains of C. botulinum toxigenic types A and B (see Tables 1 and 2 ). The isolates, which had been associated with cases of botulism, came from the stock collection of the Centers for Disease Control, Atlanta, Ga., and the Johns Hopkins Hospital In-* Corresponding author.
fectious Disease Research Laboratory. Details of their isolation and confirmation of their identity have been described previously (2) .
Fecal specimens. Nine fecal specimens from cases of infant botulism confirmed at the Centers for Disease Control (eight cases) and our laboratory (one case) were used. At the time of the original examination, each specimen was suspended in sufficient sterile gelatin diluent (0.2% gelatin, 0.4% Na2HPO4, adjusted to pH 6.2 with HCl) so that a satisfactory extract for mouse bioassay could be obtained (3) . A small sample of each specimen was maintained in a frozen state at -20°C and used in this and other studies (3).
Antitoxins. Type A, B, and polyvalent (A, B, C, D, E, and F) botulinum antitoxins were obtained from the Centers for Disease Control. Rabbit antisera specific for type A and B botulinum toxins from our previous studies (1; Dezfulian and Bartlett, in press) were used. Culture media. Media used included chopped-meatglucose (CMG) broth (Scott Laboratories, Inc., Fiskeville, R.I.), egg yolk agar (EYA), and CBI medium. The last two media were prepared in our laboratory.
The selective CBI medium was prepared by a previously described method (4) Isolation of C. botulinum from feces. Fecal specimens were streaked onto prereduced CBI media. Typical lipase-positive colonies were isolated and further identified as C. botulinum by biochemical testing and gas-liquid chromatographic analysis, as described previously (2, 5 Colony toxicity testing. The lipasé-positive colonies appearing on EYA (stock strains) or CBI agar plates (stool isolates) were uniformly suspended in 0.01 M phosphate-buffered saline solution (pH 7.4) containing 0.05% Tween 20 and 0.5% gelatin (usually 1 or 2 colonies were suspended in 0.25 or 0.50 ml of diluent). The cell suspension was then centrifuged at 4°C, and the supernatant fraction was tested in triplicate by the ELISA (1, 9; Dezfulian and Bartlett, in press). In addition to 27 type A and 23 type B strains of C. botulinum, 6 C. sporogenes strains were used as nontoxigenic control specimens. The diagnostic limits for positive ELISA readings were based on absorbance values exceeding 3 deviations above the mean value obtained with the six C. sporogenes strains. The limit was 0.01 for both type A and type B specimens.
Bacterial count. Various dilutions of the test specimens were cultured anaerobically on CBI plates, as described previously (4) .
Quantitation of toxin elaborated by C. botulinum in solid versus liquid medium. Several C. botulinum type A and B isolates were grown in CMG broth or EYA medium. The colonies appearing on EYA plates were tested after incubation for 2 days, and the broth cultures were tested after incubation for 4 days at 37°C in an anaerobe chamber (Coy Manufacturing Co., Ann Arbor, Mich.). A heavy suspension of the colonies was made in a tube containing phosphatebuffered saline-gelatin buffer. Various dilutions of centrifuged supernatants of the colony suspension or the broth culture were then examined by using the mouse bioassay (2, 7) and ELISA (1, 9; Dezfulian and Bartlett, in press), as described previously. In the mouse bioassay, 0.4-ml portions of the test specimens were injected intraperitoneally. In the ELISA, 25-,ul portions of the sample were added to microtiter, wells containing 75 pul of phosphate-buffered saline-gelatin with Tween 20 (1). The minimum lethal dose was defined as the highest dilution of toxin which caused death, following typical symptoms of botulism, in all the mice. RESULTS Table 2) . None of the six C. sporogenes strains similarly tested were toxigenic. The ELISA readings for the negative specimens were <0.005 with type A and <0.003 with type B antitoxin. Of the 42 C. botulinum strains tested, only one (strain B43) appeared nontoxigenic under the experimental conditions ( Table 2 ). The concentrated cell suspension of this strain, however, contained detectable toxin level as judged by ELISA (absorbance value of 0.11) and mouse bioassay (10 minimum lethal doses per ml). All six strains of C. sporogenes similarly tested with strain B43 were negative in the assays.
Results
Toxigenicity of colonies isolated from stool samples. At 24 to 48 h after the direct culturing of stool samples on CBI agar medium, typical lipase-positive colonies appeared on the surface of the plates. These colonies proved to be toxigenic when tested by the ELISA. Results of testing for botulinal toxin are shown in Table 3 . The serotype of the isolates, as previously determined by conventional mouse bioassay and ELISA, are also shown.
DISCUSSION
In this study we describe a rapid procedure for the selective isolation of C. botulinum by using CBI plates and direct toxicity testing of the colonies by ELISA. The entire procedure for isolation and identification of the organism can be completed in 2 to 3 days, compared with 7 to 14 days by conventional culture and mouse assay. The level of toxin associated with a concentrated suspension of 48-h-old botulinum colonies was shown to be as high as that in 4-day-old CMG broth culture, which is currently advocated for toxin detection. The colony cell suspensions used in these experiments contained between 1 x 109 and 8 x 109 bacterial cells and 102 to 105 minimum lethal doses per ml. Since the number of cells present in a typical C. botulinum colony was estimated to be 107 per ml, a limited number of colonies appeared sufficient for testing. This was borne out when one or a combination of two colonies derived from 41 additional C. botulinum type A and B strains was tested for toxigenic potential by the ELISA. In the case of a type B strain of low toxigenicity, botulinum toxin was demonstrable only in concentrated bacterial cell suspension. Our in vitro procedure for identification of C. botulinum should prove useful for large-scale serological screening of food and clinical specimens. Furthermore, this method, combined with ELISA for the direct detection of toxin in fecal specimens (3), could be used for rapid laboratory confirmation of infant botulism.
